Oxford Technology 2 VCT PLC
Interim Management Statement
For the Second Half of 2010
Oxford Technology 2 VCT PLC presents its interim management statement for the
period ended 13 December 2010, as required by the UK Listing Authority's
Disclosure and Transparency Rule 4.3.
The unaudited net asset value per ordinary share as at 30 November 2010 was
42p. Â This is a 1p increase from the last quarter ending 31 August 2010. Â The
number of ordinary shares in issue is 6,792,923.
During the quarter a loan was made to Orthogem for £4k.  Insense Ltd has spun
out a partnership called Archimed which will concentrate on wound care
technology whilst Insense will focus on dermatology and other potential
applications for its technologies.
There were no disposals. Â Freehand Surgical has been put into administration and
the carrying value has been reduced to zero.
The Directors are not aware of any other events or transactions which have taken
place between 31 August 2010 and the publication of this statement which have
had a material effect on the financial position of the company.
Enquiries:
Lucius Cary, Oxford Technology Management
01865 784466
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Oxford Technology 2 VCT plc via Thomson Reuters ONE
[HUG#1472246]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.